Katie E. Barber

2.1k total citations
89 papers, 1.5k citations indexed

About

Katie E. Barber is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, Katie E. Barber has authored 89 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Infectious Diseases, 31 papers in Pharmacology and 26 papers in Epidemiology. Recurrent topics in Katie E. Barber's work include Antimicrobial Resistance in Staphylococcus (37 papers), Antibiotics Pharmacokinetics and Efficacy (30 papers) and Bacterial Identification and Susceptibility Testing (26 papers). Katie E. Barber is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (37 papers), Antibiotics Pharmacokinetics and Efficacy (30 papers) and Bacterial Identification and Susceptibility Testing (26 papers). Katie E. Barber collaborates with scholars based in United States, United Kingdom and Canada. Katie E. Barber's co-authors include Michael J. Rybak, Kayla R. Stover, Jordan R. Smith, Jamie L. Wagner, Brian J. Werth, Jason M. Pogue, George Sakoulas, Keith S. Kaye, S. Travis King and D. Collett and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gut and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Katie E. Barber

87 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katie E. Barber United States 21 827 471 421 405 371 89 1.5k
Sailaja Puttagunta United States 21 945 1.1× 324 0.7× 505 1.2× 458 1.1× 285 0.8× 45 1.6k
Yu‐Chung Chuang Taiwan 27 909 1.1× 1.0k 2.2× 373 0.9× 294 0.7× 613 1.7× 122 2.3k
William O’Riordan United States 20 1.1k 1.3× 493 1.0× 627 1.5× 431 1.1× 323 0.9× 38 1.8k
Barry Hafkin United States 20 1.4k 1.6× 416 0.9× 631 1.5× 410 1.0× 354 1.0× 35 2.0k
Sun Young Cho South Korea 25 872 1.1× 445 0.9× 252 0.6× 173 0.4× 337 0.9× 145 2.0k
Laurent Massias France 26 588 0.7× 567 1.2× 200 0.5× 562 1.4× 534 1.4× 71 1.8k
H. David Friedland United States 19 958 1.2× 529 1.1× 440 1.0× 594 1.5× 345 0.9× 39 1.5k
Jennifer S. McDanel United States 13 667 0.8× 357 0.8× 337 0.8× 175 0.4× 187 0.5× 25 1.1k
Michael Kresken Germany 21 448 0.5× 474 1.0× 310 0.7× 426 1.1× 669 1.8× 73 1.4k
Eileen Graffunder United States 11 772 0.9× 385 0.8× 649 1.5× 268 0.7× 353 1.0× 16 1.5k

Countries citing papers authored by Katie E. Barber

Since Specialization
Citations

This map shows the geographic impact of Katie E. Barber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katie E. Barber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katie E. Barber more than expected).

Fields of papers citing papers by Katie E. Barber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katie E. Barber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katie E. Barber. The network helps show where Katie E. Barber may publish in the future.

Co-authorship network of co-authors of Katie E. Barber

This figure shows the co-authorship network connecting the top 25 collaborators of Katie E. Barber. A scholar is included among the top collaborators of Katie E. Barber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katie E. Barber. Katie E. Barber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barber, Katie E., Gerry P McCann, Iain Squire, et al.. (2025). Developing core indicators for identifying people at risk of delayed heart failure diagnosis. BMC Primary Care. 26(1). 316–316.
2.
Jayasena, Channa, Katie E. Barber, Alexander Comninos, et al.. (2024). Society for endocrinology guideline for understanding, diagnosing and treating female hypogonadism. Clinical Endocrinology. 101(5). 409–442. 11 indexed citations
3.
Pogue, Jason M., et al.. (2024). Tebipenem and Sulopenem: Dynamic Duo or Double Trouble?. Current Infectious Disease Reports. 26(5). 139–150. 7 indexed citations
4.
Barber, Katie E., et al.. (2023). Treatment decisions in VRE bacteraemia: a survey of infectious diseases pharmacists. JAC-Antimicrobial Resistance. 5(3). dlad063–dlad063. 3 indexed citations
5.
Stover, Kayla R., Jamie L. Wagner, Katie E. Barber, et al.. (2023). Evaluation of an Antifungal Stewardship Initiative Targeting Micafungin at an Academic Medical Center. Antibiotics. 12(2). 193–193. 1 indexed citations
6.
Wagner, Jamie L., Katie E. Barber, P. Brandon Bookstaver, et al.. (2022). Rethinking residency recruitment, application, and interview processes to benefit applicants and programs long-term. Journal of the American Pharmacists Association. 62(6). 1756–1760. 1 indexed citations
7.
Briggs, Paula, Katie E. Barber, Tim Hillard, et al.. (2022). Consensus-led recommendations supporting choice and personalisation of Hormone replacement therapy in menopause care. Post Reproductive Health. 28(2). 71–78. 2 indexed citations
8.
9.
Dreger, Dayna L., et al.. (2022). ABCG2 Polymorphisms and Predictive Fluoroquinolone Phototoxicity in Nondomestic Felids. Genes. 13(12). 2178–2178. 1 indexed citations
10.
Rebold, Nicholas, Taylor Morrisette, Abdalhamid M Lagnf, et al.. (2021). Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections. Open Forum Infectious Diseases. 8(12). ofab554–ofab554. 24 indexed citations
11.
Wagner, Jamie L., Katie E. Barber, & Kayla R. Stover. (2021). Activities to enhance introductory pharmacy practice experiences. Currents in Pharmacy Teaching and Learning. 13(9). 1127–1134. 2 indexed citations
12.
Bojikian, Karine D., et al.. (2017). Successful Treatment of Necrotizing Fasciitis and Streptococcal Toxic Shock Syndrome with the Addition of Linezolid. SHILAP Revista de lepidopterología. 2017. 1–3. 15 indexed citations
13.
King, S. Travis, et al.. (2017). Shifts in antimicrobial consumption and infection rates before and during a piperacillin/tazobactam shortage. Journal of Global Antimicrobial Resistance. 11. 111–113. 11 indexed citations
14.
Stover, Kayla R., et al.. (2017). Time–Kill Analysis of Ceftolozane/Tazobactam Efficacy Against Mucoid Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients. Infectious Diseases and Therapy. 6(4). 507–513. 5 indexed citations
15.
Stover, Kayla R., et al.. (2017). Mechanisms of fosfomycin resistance in carbapenem-resistant Enterobacter sp .. International Journal of Antimicrobial Agents. 50(5). 690–692. 6 indexed citations
16.
Akins, Ronda L., Katie E. Barber, & Kelli L. Palmer. (2016). Pronounced heterogeneity observed in high-level daptomycin-resistant viridans group streptococci. Journal of Global Antimicrobial Resistance. 7. 159–166. 2 indexed citations
17.
Smith, Jordan R., et al.. (2015). β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. Journal of Antimicrobial Chemotherapy. 70(6). 1738–1743. 100 indexed citations
18.
Barber, Katie E., S. Travis King, Kayla R. Stover, & Jason M. Pogue. (2015). Therapeutic options for vancomycin-resistant enterococcal bacteremia. Expert Review of Anti-infective Therapy. 13(3). 363–377. 28 indexed citations
19.
Rybak, Jeffrey M., Katie E. Barber, & Michael J. Rybak. (2013). Current and prospective treatments for multidrug-resistant gram-positive infections. Expert Opinion on Pharmacotherapy. 14(14). 1919–1932. 37 indexed citations
20.
Barber, Katie E., et al.. (2009). Quantitative in vitro and in vivo characterization of the human P32T mutant ITPase. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802(2). 269–274. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sailaja Puttagunta Breakdown of academic impact, for papers by Yu‐Chung Chuang Breakdown of academic impact, for papers by William O’Riordan Breakdown of academic impact, for papers by Barry Hafkin Breakdown of academic impact, for papers by Sun Young Cho Breakdown of academic impact, for papers by Laurent Massias Breakdown of academic impact, for papers by H. David Friedland Breakdown of academic impact, for papers by Jennifer S. McDanel Breakdown of academic impact, for papers by Michael Kresken Breakdown of academic impact, for papers by Eileen Graffunder
Rankless by CCL
2026